Neutrophil percentage-to-albumin Ratio Predicts Mortality in Bladder Cancer Patients Treated With Neoadjuvant Chemotherapy Followed By Radical CystectomyMatteo Ferro, Mihai Dorin Vartolomei, Dragoș-Florin Babă et al.|Future Science OA|2021Cited by 79
Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional databaseAnnamaria Porreca, Michele Marchioni, Marta Di Nicola et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 9
Enhanced recovery after surgery (ERAS) program in octogenarian patients: a propensity score matching analysis on the “Lazio Network” databaseMichele Grieco, Andrea Sagnotta, Graziano Pernazza et al.|Langenbeck s Archives of Surgery|2022Cited by 4